أفضل الأطراف الاصطناعية - توب -212 أطباء

• خبير في الأطراف الاصطناعية وتقويم العظام، مع التركيز على إعادة تأهيل الأطراف المفقودة.
• متخصص في الأطراف الصناعية المخصصة والأقواس التقويمية.
• يستخدم مواد متقدمة لتحسين الملاءمة والوظيفة في الأطراف الاصطناعية.
• يستخدم التدريب على المشي وتعليم المريض من أجل التكامل الأمثل لتقويم العظام.
• الخبرة المهنية في جميع أنحاء ألمانيا في أفضل المؤسسات الطبية.
• العضوية في Deutsche Gesellschaft für Onkologie und Hämato-Onkologie (GDHO).
• عضو الجمعية الأمريكية لأبحاث السرطان، مما يشير إلى منظور عالمي.
• مراجع نظير للمجلات العلمية، مما يضمن المعرفة العلاجية الحديثة.
• لم يتم توفير معدلات نجاح أو تصنيفات محددة للأطراف الصناعية وتقويم العظام.
• لا توجد شهادات مدرجة تتعلق مباشرة بالأطراف الصناعية وتقويم العظام.

EXPERIENCE*

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

*EDUCATION*

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

Andrew Foggitt is a UK-trained Consultant Orthopedic Surgeon who studied at Liverpool University Medical School, before undertaking his surgical and orthopedic training in the Wessex region of the South of England. He passed the orthopedic exit exam in 2000 and took up a Consultant post in November 2002 in Winchester, UK, as a General Orthopedic Surgeon with a specialist interest in foot and ankle surgery. This was a new post, and he set up a foot and ankle service, which was sufficiently successful, that he had to give up his general orthopedic practice to concentrate on purely foot and ankle surgery, which he continued, for over 19 years before moving to the Burjeel Hospital in Dubai, full-time, to provide foot and ankle services to the local population. He is supported by an integrated hospital team, providing a holistic service, including nurses, physiotherapists, podiatrists, orthotics, and a dedicated back-room team who will assist you through your hospital journey. He looks forward to providing you with personalized service to look after your foot and ankle problems. His areas of expertise include, 

• Arthritic conditions of the foot and ankle
• Sports injuries of the ankle
• Ankle arthroscopy
• Tendon transfers
• Reconstructive surgery
• Achilles tendon disorders
• Plantar fasciitis
• Curly toes, bunions, and ingrowing toenails